Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Payables (2019 - 2025)

Silo Pharma (SILO) has disclosed Payables for 7 consecutive years, with $578081.0 as the latest value for Q4 2025.

  • Quarterly Payables fell 63.5% to $578081.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $578081.0 through Dec 2025, down 63.5% year-over-year, with the annual reading at $578081.0 for FY2025, 63.5% down from the prior year.
  • Payables hit $578081.0 in Q4 2025 for Silo Pharma, down from $636237.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.6 million in Q4 2024 to a low of $92095.0 in Q3 2023.
  • Historically, Payables has averaged $619488.1 across 5 years, with a median of $578081.0 in 2025.
  • Biggest five-year swings in Payables: surged 956.22% in 2024 and later tumbled 63.5% in 2025.
  • Year by year, Payables stood at $417937.0 in 2021, then fell by 12.85% to $364216.0 in 2022, then skyrocketed by 93.15% to $703488.0 in 2023, then surged by 125.15% to $1.6 million in 2024, then plummeted by 63.5% to $578081.0 in 2025.
  • Business Quant data shows Payables for SILO at $578081.0 in Q4 2025, $636237.0 in Q3 2025, and $977795.0 in Q2 2025.